AVEO Oncology
AVEO
#7144
Rank
NZ$0.86 B
Marketcap
NZ$24.92
Share price
0.00%
Change (1 day)
150.48%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$88.61 Million a decrease over its 2020 earnings that were of -NZ$59.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-49.83%
2021 -NZ$88.61 Million49.9%
2020 -NZ$59.11 Million-479.04%
2019 NZ$15.59 M-276.17%
2018 -NZ$8.86 Million-91.79%
2017 -NZ$0.11 Billion142.38%
2016 -NZ$44.5 Million78.51%
2015 -NZ$24.93 Million-71.55%
2014 -NZ$87.6 Million-50.72%
2013 -NZ$0.18 Billion-4.88%
2012 -NZ$0.19 Billion-426.29%
2011 NZ$57.27 M-159.85%
2010 -NZ$95.72 Million35.33%
2009 -NZ$70.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$37.37 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.69 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.16 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.54 B-17,817.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.34 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.76 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA